ANALYTICAL REPORT. Flubromazepam (C15H10BrFN2O) powder - white

Similar documents
ANALYTICAL REPORT. 5C-AKB48 (C23H30ClN3O) powder - white Sample type: Comments 1 : Remark other NPS detected: none

ANALYTICAL REPORT MDPHP (C17H23NO3) powder - brown dark Sample type: Comments 1 : Remark other NPS detected: Sample ID: Sample description:

ANALYTICAL REPORT 1 5F-APP-PICA(PX1) (C23H26FN3O2) N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide

ANALYTICAL REPORT 1 AKB-57 (C23H30N2O2) adamantan-1-yl 1-pentyl-1H-indazole-3-carboxylate.

ANALYTICAL REPORT 1 FUB-AMB ( C21H22FN3O3) methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazol-3-yl}formamido)-3-methylbutanoate

ANALYTICAL REPORT 1 5F-AKB48 (C23H30FN3O) N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indazole-3 carboxamide

ANALYTICAL REPORT 1. 4Cl-PVP (C15H20ClNO) Remark other NPS detected: none. 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one. Sample ID:

ANALYTICAL REPORT 1. alpha-php (C16H23NO) 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one.

ANALYTICAL REPORT 1. 4-CIC (C12H16ClNO) 1-(4-chlorophenyl)-2-(isopropylamino)propan-1-one.

ANALYTICAL REPORT 1. 4-CEC (C11H14ClNO) Remark other NPS detected: none. 1-(4-chlorophenyl)-2-(ethylamino)propan-1-one. Sample ID:

ANALYTICAL REPORT. Isopropyl-U (C18H26Cl2N2O) 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-(propan-2-yl)benzamide

ANALYTICAL REPORT 1. 3-MeO-PCP (C18H27NO) Remark other NPS detected: none. 1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine. Sample ID:

ANALYTICAL REPORT 1. RTI-111 (C16H19Cl2NO2) methyl 3-(3,4-dichlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate

ANALYTICAL REPORT 1 MDMB-CHMCZCA (C27H34N2O3) methyl-2-(1-(cyclohexylmethyl)-9h-carbazol-3-ylcarbonylamino)-3,3-dimethylbutanoate

ANALYTICAL REPORT 1. Methoxyacetyl-F (C22H28N2O2) 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide

ANALYTICAL REPORT THF-F (C24H30N2O2) N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide

Acknowledgement: 4F-PBP (C14H18FNO) T: +386 (0) E: Vodovodna Ljubljana SLOVENIJA

ANALYTICAL REPORT 1 1P-LSD (C23H29N3O2) N,N-diethyl-7-methyl-4-propanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-

ANALYTICAL REPORT 1. 4-Me-TMP (C15H21NO2) Remark other NPS detected: none. sample contains some impurities (benzeneacetic acid + others)

ANALYTICAL REPORT 1 CUMYL-4CN-BINACA (C22H24N4O) 1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide

ANALYTICAL REPORT 1 25I-NBOH (C17H20INO3) 2-({[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol

ANALYTICAL REPORT. 25B-NBOH (C17H20BrNO3) 2-({[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol RSUNJYKZRKIBNB-UHFFFAOYSA-N

Preparation of endohedral fullerene containing lithium 60 ) and isolation as pure hexafluorophosphate salt ([Li 60 ][PF 6 ])

Supporting Information

High-resolution probes for 19 F applications. Aitor Moreno Bruker BioSpin, Switzerland BeNeLux NMR User Meeting 2016, Brussels 25 th of November 2016

Supporting Information

Diels-Alder Approach to Biaryls (DAB): Importance of the ortho-nitro Moiety in the [4+2] Cycloaddition.

Supplementary Information UNEXPECTED REDUCTION OF INDOLE DOUBLE BOND IN MITRAGYNINE USING N-BUTYLSILANE AND CATALYTIC TRIS(PENTAFLOROPHENYL)BORANE

Gulaim A. Seisenbaeva,, Geoffrey Daniel, Jean-Marie Nedelec,, Vadim G. Kessler,*, Supplementary materials

Supporting Information. Copyright Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, 2008

Asymmetric Hydrogenation of Imines with Recyclable Chiral Frustrated Lewis Pair Catalyst

-SUPPORTING INFORMATION-

2,5-DIMETHOXY-4-IODOPHENETHYLAMINE Latest Revision: August 22, 2005

MassHunter METLIN Metabolite PCD/PCDL Quick Start Guide

Pharmaceutical Impurity Identification and Profiling Using Agilent Q-TOF LC/MS Combined with Advanced MassHunter Data Processing Software

AstraZeneca, Pharmaceutical Sciences, Silk Road Business Park, Macclesfield, SK10 2NA, UK

Indigenous development of Novel Magnesium Precursor and High Performance Ziegler-Natta Catalysts for Polypropylene & Polyethylene

Accurate Mass Analysis of Hydraulic Fracturing Waters: Identification of Polyethylene Glycol Surfactants by LC/Q-TOF-MS

Synthesis, Characterization and Antimicrobial screening of some Azo compounds derived from Ethyl vanillin

Supporting Information. Solvent-Coordinated Tin Halide Complexes as Purified Precursors for Tin-based Perovskites

Chemical characterizations and reporting of new psychoactive substances RESPONSE project methodologies

Accurate Mass Analysis of Hydraulic Fracturing Waters

Final Report. Characterisation of Sample Report. Job No 2016/11/12-34 AS No. 1234A. Client Example Contact Sample. Signed Date 2017.

SUPPORTING INFORMATION. Titania-Catalyzed Radiofluorination of Tosylated Precursors in Highly Aqueous Medium

Asymmetric Michael Reaction of Aldehydes and Nitroalkenes

The Agilent 1260 Infinity Analytical SFC System with Time-of-Flight Mass Spectrometric Detection

Agilent 1290 Infinity Quaternary LC Stepwise Transfer to Methods with MS-Compatible Mobile Phases

The Agilent InfinityLab 2D-LC Solution with Active Solvent Modulation

Agilent G3212 GC-APCI Source

An Effective Workflow for Impurity Analysis Incorporating High Quality HRAM LCMS & MSMS with Intelligent Automated Data Mining

High-Resolution Sampling 2D-LC for Pharmaceutical Impurity Analysis

Supporting Information. Enantioselective Organocatalyzed Henry Reaction with Fluoromethyl Ketones

PI(17:0/14:1(9Z)) (Proton Form) (Ammonium salt Form) (Proton Form) (Ammonium salt Form) LMGP / LM7-112B

Selective Formation of Benzo[c]cinnoline by Photocatalytic Reduction of 2,2 Dinitrobiphenyl with TiO 2 and UV light irradiation

Determination of EU-Banned Disperse Dyes by LC/MSD TOF Application

Analysis of Gamma butyrolactone for registration according REACH. Report no. JK 75/17

Rapid method development to study plasma stability of diverse pharmaceutical compounds using Rapid Resolution LC and triple quadrupole MS

Screening of Pharmaceuticals and Personal Care Products in Effluents and Surface Waters with LCMS Q-TOF

Certificate of Analysis

(proton form) (ammonium salt) (proton form) (ammonium salt) LMGP / LM1-057A. -16 to -24 C

Analyzing Compounds of Environmental Interest Using an LC/Q-TOF Part 1: Dyes and Pigments. Application. Introduction. Authors. Abstract.

Agilent ESI and APCI sources: for polar to non-polar compounds

Separation of Enantiomers of Amphetamine-Related Drugs and Their Structural Isomers

Using UHPLC-Triple Quadrupole MS/MS to Detect the Presence of Bark Extract and Yohimbine Adulteration in Dietary Supplements and Botanicals

Supporting Information

Accurate Mass Measurement for Intact Proteins using ESI-oa-TOF. Application Note. Donghui Yi and Christine Miller Agilent Technologies

Application Note. Edgar Naegele. Abstract

Supporting Information

BUFOTENINE Latest Revision: August 16, 2005

Determination of Beta-Blockers in Urine Using Supercritical Fluid Chromatography and Mass Spectrometry

Certified Reference Material - Certificate of Analysis Methylone, Primary Standard

Rapid and Accurate Forensics Analysis using High Resolution All Ions MS/MS

LC/MS/MS qua ntitation of β-estradiol 17-acetate using an Agilent 6460 Triple Quadrupole LC/MS working in ESI negative ion mode

Mass Spectrometry Reference Standard 1-Heptadecanoyl-2-(5Z,8Z,11Z,14Z-Eicosatetraenoyl)-sn-Glycero-3-Phospho- (1 -Myo-Inositol)(Ammonium Salt)

Agilent 6400 Series Triple Quadrupole Users Workshop. MH QQQ Users workshop 2/21/2014 1

Evaluation of bishexadecyltrimethyl ammonium palladium tetrachloride based dual. functional colloidal carrier as an antimicrobial and anticancer agent

Array-Based Sensing of Explosives by Water- Soluble Poly(para-phenyleneethynylene)s

5Cl-AKB48 and 5Br-AKB48

The Focus Robotic Sample Processor as a Tool for the Multiple Analysis of Samples using Complementary Techniques

NCFS Sample Preparation and Instrumental Parameters

Analysis of Low-Calorie Sweeteners by Liquid Chromatography-Tandem Mass Spectrometry

Supplementary Information. Low volume shrinkage polymers by photo Polymerization of 1,1- Bis(ethoxycarbonyl)-2-vinylcyclopropanes

GC-CI-MS analysis of TMS derivatives

Accelerating the Metabolite Identification Process Using High Resolution Q-TOF Data and Mass-MetaSite Software

2-[[2-(4-ethyl-2,5-dimethoxy-phenyl)ethylamino]methyl]phenol

4-Methyldiethcathinone (4-MDEC)

Clinical Toxicology. Biomass Component Extraction: The uneaten cooked plant specimen was prepared for

Analysis of Stachydrine in Leonurus japonicus Using an Agilent ZORBAX RRHD HILIC Plus Column with LC/ELSD and LC/MS/MS

Using TOF for Screening and Quantitation of Sudan Red Colorants in Food Application

Certified Reference Material - Certificate of Analysis

1-(1,3-benzodioxol-5-yl)-2-(ethylamino)hexan-1-one

Joint Research Centre. The European Commission's in-house science service

Measuring Drug-to-Antibody Ratio (DAR) for Antibody-Drug Conjugates (ADCs) with UHPLC/Q-TOF

Agilent 6400 Series Triple Quadrupole LC/MS/MS Users Session

Determination of Pharmaceuticals in Water by SPE and LC/MS/MS in Both Positive and Negative Ion Modes Application

Supporting Information

Total Synthesis of ( )-Cryptocaryol A

MassHunter TOF/QTOF Users Meeting

5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE Latest Revision: June 20, 2005

Contents. Efficient synthesis of 5-(chloromethyl)furfural (CMF) from high fructose corn syrup (HFCS) using continuous flow processing

Transcription:

Vodovodna 95 000 Ljubljana SLOVENIJA T: +386 (0) 428 44 93 Remark other NPS detected: none Sample ID: 92-5 Sample description: Sample type: Comments : Date of entry: 0/5/205 ANALYTICAL REPORT Flubromazepam (C5H0BrFN2O) 7-bromo-5-(2-fluorophenyl)-,3-dihydro-2H-,4-benzodiazepin-2-one powder - white test purchase (RESPONSE -purchasing) E: nfl@policija.si www.policija.si Substance identifiedstructure 2 (base form) Systematic name 7-bromo-5-(2-fluorophenyl)-,3-dihydro-2H-,4-benzodiazepin-2-one Other names Formula (per base form) C5H0BrFN2O M w (g/mol) 333,5 Salt form StdInChIKey Compound Class Other NPS detected base ZRKDDZBVSZLOFS-UHFFFAOYSA-N Benzodiazepines none Add.info (purity..) This report has been produced with the financial support of the P r e v e n t i o n o f a n d f i g h t a g a i n s t c r i m e Programme of the European Union (grant agreement number JUST/203/ISEC/DRUGS/AG/643). The contents of this report are the sole responsibility of the National Forensic Laboratory and can in no way be taken to reflect the views of the European Commission. 2 Created by OPSIN free tool: http://opsin.ch.cam.ac.uk/ DOI: 0.02/ci00384d Stran od 5 ID92-5

92-5_na Report updates date comments (explanation) Instrumental methods (if applied) in NFL. GC-MS (Agilent): GC-method is RT locked to tetracosane (RT=9.53 min). Injection volume ml and split mode (:50). Injector temperature: 280 0 C. Chromatographic separation: on column HP-MS (00% dimethylpolysiloxane), length 30 m, internal diameter 0.25 mm, film thickens 0.25 mm. Carrier gas He: flow-rate.2 ml/min. GC oven program: 70 0 C for min, followed by heating up to 293 0 C at a rate of 8 0 C/min, hold for 6. min, than heating at 50 0 C/min up to 325 0 C and finally 2.8 min isothermal. MSD source EI = 70 ev. GC-MS transfer line T= 235 0 C, source and quadropole temperatures 280 0 C and 80 0 C, respectively. Scan range m/z scan range: from 50 (40) to 550 amu. 2. HPLC-TOF (Agilent): 6230B TOF with Agilent 260 Infinity HPLC with binary pump, column: Zorbax Eclipse XDB- C8, 50 x 4.6 mm,.8 micron. Mobile phases (A) 0.% formic acid and mm ammonium formate in water; (B) 0.% formic acid in methanol (B). Gradient: starting at 5% B, changing to 40% B over 4 min, then to 70% over 2 min and in 5 min to 00%, hold min and back to 5%, equilibration for.7 min. The flow rate:.0 ml/min; Injection volume µl. MS parameters: 2GHz, Extended Dynamic range mode to a maximum of 700 amu, acquisition rate.30 spectra/sec. Sample ionisation: by Agilent Jet Stream technology (Dual AJS ESI). Ion source: positive ion scan mode with mass scanning from 82 to 000 amu. Other TOF parameters: drying gas (N2) and sheath temperature 325 C; drying gas flow rate 6 l/min; sheath gas flow rate 8 l/min; nebulizer 25 psig; Vcap. 4000 V; nozzle 2000 V; skimmer 65 V; fragmentor 75 V and Octopole RF 750 V. 3. FTIR-ATR (Perkin Elmer): scan range 4000-400 cm - ; resolution 4 cm - 3.FTIR-ATR (Perkin Elmer): scan range 4000-400 cm-; resolution 4cm- 4. GC- (MS)-IR condensed phase (GC-MS (Agilent) & IR (Spectra analyses-danny) GC-method: Injection volume ml and split mode (:5). Injector temperature 280 0 C. Chromatographic separation as above (). Split MS : IR = :9. MSD source EI = 70 ev. GC-MS transfer line T= 235 0 C, source and quadropole temperatures 280 0 C and 80 0 C, respectively. Scan range m/z scan range: from 50 (40) to 550 amu. IR (condesed phase): IR scan range 4000 to 650, resolution 4 cm -. Stran 2 od 5 ID 92-5

92-5_na Supporting information Solubility in CH 2 Cl 2 MeOH other result/remark soluble soluble not tested Analytical technique: applied remarks GC-MS (EI ionization) + NFL GC-RT (min): 9,99 BP(): 304; BP(2): 303,BP(3) :305, extr. CH2Cl2 HPLC-TOF + Exact mass (theoretical): 33,996; measured value Δppm:-0,03; formula:c5h0brfn2o FTIR-ATR + direct measurement FTIR (condensed phase) always as base form + ex. CH2Cl2 HPLC-TOF + Exact mass (theoretical): 33,996; measured value Δppm:-0,03; formula:c5h0brfn2o NMR + validation other pure by GG, HPLC, NMR Stran 3 od 5 ID 92-5

92-5_na ANALYTICAL RESULTS MS (EI) Stran 4 od 5 ID 92-5

92-5_na FTIR-ATR IR (condensed phase) Stran 5 od 5 ID 92-5

Target Compound Screening Report Data File Flubromazepam_92-5_TOF.d Sample Name Flubromazepam Sample Type Sample Position P-D2 Instrument Name 6230B TOF LC-MS User Name Acq Method droge general-3-5-205-xdb-c8-esi-poz.m Acquired Time 7/27/205 0:38:5 AM IRM Calibration Status Comment Success DA Method Droge_Default.m extract in MeOH Compound Table Label Tgt Name MFG Formula Obs. RT Obs. Mass Cpd : Flubromazepam Flubromazepam C5 H0 Br F N2 O 7.744 33.996 Name Obs. m/z Obs. RT Obs. Mass DB RT DB Formula DB Mass Flubromazepam 333.0033 7.744 33.996 7.74 C5 H0 Br F N2 O 33.996-0.03 Compound Chromatograms DB Mass Error (ppm) Find Cpds Algorithm Find by Molecular Feature x0 7 Cpd : Flubromazepam: +ESI EIC(333.0035, 334.00 x0 7 Cpd : Flubromazepam: +ESI ECC Scan Frag=75..8.8.6.6.4.4.2.2 0.8 0.8 0.6 0.6 0.4 0.4 0.2 0.2 0 7 7.2 7.4 7.6 7.8 8 8.2 8.4 8.6 Counts vs. Acquisition Time (min) 0 7.8 7.9 8 8. 8.2 8.3 Counts vs. Acquisition Time (min) MFE MS Zoomed Spectrum x0 6 Cpd : Flubromazepam: +ESI MFE Spectrum (rt: 7.699-8.366 min) Frag=75.0V Flubromazepam 6 5 4 3 2 0 320 340 360 380 400 420 440 460 480 500 520 540 560 580 600 620 640 660 680 700 720 Counts vs. Mass-to-Charge (m/z) MS Spectrum Peak List Obs. m/z Charge Abund Formula Ion/Isotope Page of 2 Printed at :39 AM on 27-Jul-205

Target Compound Screening Report 333.0033 735505.5 C5 H0 Br F N2 O (M+H)+ 334.0069 85309.57 C5 H0 Br F N2 O (M+H)+ 335.003 7059902.39 C5 H0 Br F N2 O (M+H)+ 336.0048 39577.94 C5 H0 Br F N2 O (M+H)+ 354.9852 63052.95 C5 H0 Br F N2 O (M+Na)+ 356.9835 62900.45 C5 H0 Br F N2 O (M+Na)+ 686.98 239342.3 C5 H0 Br F N2 O (2M+Na)+ 688.9796 507278.22 C5 H0 Br F N2 O (2M+Na)+ 689.982 58608.6 C5 H0 Br F N2 O (2M+Na)+ 690.978 256964.89 C5 H0 Br F N2 O (2M+Na)+ MS Zoomed Spectrum x0 6 Cpd : Flubromazepam: +ESI Scan (rt: 7.699-8.353 min, 52 scans) Frag=75.0V Flubromazepam 6 5 4 3 2 383.242 444.4043 553.388 688.9793 (2M+Na)+ 0 320 340 360 380 400 420 440 460 480 500 520 540 560 580 600 620 640 660 680 700 720 Counts vs. Mass-to-Charge (m/z) --- End Of Report --- Page 2 of 2 Printed at :39 AM on 27-Jul-205

University of Ljubljana Faculty of Chemistry and Chemical Technology Večna pot 3 P. O. Box 537 SI-00 Ljubljana Slovenia Phone: +386 479 8558 janez.kosmrlj@fkkt.uni-lj.si REPORT Sample ID: 92-5 Our notebook code: P-92-5 NMR sample preparation: 5 mg dissolved in 0.7 ml CDCl 3 NMR experiments: Proposed structure with chemical name: H, 3 C, H H gs-cosy, H 3 C gs-hsqc, H 3 C gs-hmbc, H 5 N gs-hmbc. Br F NH O N 7-bromo-5-(2-fluorophenyl)-,3-dihydro-2H-benzo[e][,4]diazepin-2-one Comments: - Structure elucidation based on D and 2D NMR spectra - Compound is pure by NMR Supporting information: Copies of H and 3 C NMR spectra Author: Prof. Dr. Janez Košmrlj, Doc. Dr. Krištof Kranjc Date of report: September 30, 205 This report has been produced with the financial support of the Prevention of and fight against crime Programme of the European Union (grant agreement number JUST/203/ISEC/DRUGS/AG/643). The contents of this publication are the sole responsibility of the Author and can in no way be taken to reflect the views of the European Commission.

P-92-5 Current Data Parameters NAME P-92-5 EXPNO PROCNO F2 - Acquisition Parameters Date_ 205085 Time 4.39 INSTRUM spect PROBHD 5 mm PABBO BB- PULPROG zg30 TD 65536 SOLVENT CDCl3 NS 6 DS 2 SWH 0330.578 Hz FIDRES 0.57632 Hz AQ 3.79923 sec RG 28 DW 48.400 usec DE 6.50 usec TE 298. K D.00000000 sec ======== CHANNEL f ======== NUC H P 8.90 usec PLW 26.00000000 W SFO 500.330885 MHz F2 - Processing parameters SI 65536 SF 500.3007 MHz WDW EM SSB 0 LB 0.30 Hz GB 0 PC.00 9 8 7 6 5 4 3 2 ppm 0.99 P-92-5 7.37.95 0.99 0.94.2.99 2.00 66.5 6.44 59.43 36.69 34.8 32.34 32.27 3.43 3.4 29.75 27.27 27.7 24.45 24.42 22.9 6.69 6.40 6.23 56.65 80 60 40 20 00 80 60 40 20 ppm Current Data Parameters NAME P-92-5 EXPNO 3 PROCNO F2 - Acquisition Parameters Date_ 205085 Time 6.42 INSTRUM spect PROBHD 5 mm PABBO BB- PULPROG zgpg30 TD 65536 SOLVENT CDCl3 NS 3072 DS 4 SWH 2976.904 Hz FIDRES 0.4543 Hz AQ.00548 sec RG 2050 DW 6.800 usec DE 6.50 usec TE 299.0 K D.00000000 sec D 0.03000000 sec ======== CHANNEL f ======== NUC 3C P 9.00 usec PLW 22.00000000 W SFO 25.7703637 MHz ======== CHANNEL f2 ======== CPDPRG2 waltz6 NUC2 H PCPD2 80.00 usec PLW2 26.00000000 W PLW2 0.327900 W PLW3 0.2059500 W SFO2 500.320005 MHz F2 - Processing parameters SI 32768 SF 25.7577899 MHz WDW EM SSB 0 LB.00 Hz GB 0 PC.40